Kitazato

Kitazato Net Tangible Assets

The Net Tangible Assets of Kitazato (368A.T) as of Nov 17, 2026 is 18.19 B JPY. In the previous year, Net Tangible Assets was 15.98 B JPY — a change of 13.80% (higher).

Net Tangible Assets

18.19 BJPY

YoY

13.80%

Last updated:

Net Tangible Assets of Kitazato is 2025 18.19 B JPY. Net Tangible Assets of Kitazato was 2024 15.98 B JPY. It decreases by 13.80% higher compared to the previous year.

The Kitazato Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2023
14.00 B JPY
Jan 1, 2024
15.98 B JPY
Jan 1, 2025
18.19 B JPY
The Kitazato Net Tangible Assets history
YEARNet Tangible AssetsYoY
18.19 BJPY+13.80%
15.98 BJPY+14.14%
14.00 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Net Tangible Assets of Kitazato is 18.19 B JPY in 2025.

Net Tangible Assets of Kitazato changed from 15.98 B JPY to 18.19 B JPY, representing a 13.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Kitazato since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Kitazato historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Kitazato

All Key Metrics — Kitazato